Suppr超能文献

印度比哈尔邦农村初级卫生保健服务中内脏利什曼病的管理。

Management of visceral leishmaniasis in rural primary health care services in Bihar, India.

机构信息

Epidemiology and Disease Control Unit, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.

出版信息

Trop Med Int Health. 2010 Jul;15 Suppl 2(Suppl 2):55-62. doi: 10.1111/j.1365-3156.2010.02562.x.

Abstract

OBJECTIVE

In 2005 a visceral leishmaniasis (VL) elimination initiative was launched on the Indian subcontinent, with early diagnosis based on a rapid diagnostic test and treatment with the oral drug miltefosine as its main strategy. Several recent studies have signaled underreporting of VL cases in the region. Information on treatment outcomes is scanty. Our aim was to document VL case management by the primary health care services in India.

METHODS

We took a random sample of all VL patients registered in rural primary health care (PHC) facilities of Muzaffarpur district, Bihar, India during 2008. Patients were traced at home for an interview and their records were reviewed. We recorded patient and doctor delay, treatment regimens, treatment outcomes and costs incurred by patients.

RESULTS

We could review records of all 150 patients sampled and interview 139 patients or their guardian. Most patients (81%) had first presented to unqualified practitioners; median delay before reaching the appropriate primary healthcare facility was 40 days (IQR 31-59 days). Existing networks of village health workers were under-used. 48% of VL patients were treated with antimonials; 40% of those needed a second treatment course. Median direct expenditure by patients was 4000 rupees per episode (IQR 2695-5563 rupees), equivalent to almost 2 months of household income.

CONCLUSION

In 2008 still critical flaws remained in VL case management in the primary health care services in Bihar: obsolete use of antimonials with high failure rates and long patient delay. To meet the target of the VL elimination, more active case detection strategies are needed, and village health worker networks could be more involved. Costs to patients remain an obstacle to early case finding.

摘要

目的

2005 年,在印度次大陆启动了内脏利什曼病(VL)消除计划,早期诊断基于快速诊断测试,以口服药物米替福新为主要策略。最近的几项研究表明,该地区 VL 病例报告不足。有关治疗结果的信息很少。我们的目的是记录印度初级卫生保健服务中 VL 病例的管理情况。

方法

我们从印度比哈尔邦穆扎法尔布尔区农村初级卫生保健(PHC)设施中随机抽取了所有 2008 年登记的 VL 患者作为样本。我们在家中追踪患者进行访谈,并审查其记录。我们记录了患者和医生的延迟、治疗方案、治疗结果以及患者的费用。

结果

我们可以查阅抽样的 150 名患者的记录并采访了 139 名患者或其监护人。大多数患者(81%)首次就诊于无资质的医生;到达适当的初级卫生保健机构的中位延迟为 40 天(IQR 31-59 天)。现有的村庄卫生工作者网络使用不足。48%的 VL 患者接受了锑剂治疗;其中 40%需要进行第二次疗程。每位患者的直接支出中位数为 4000 卢比(IQR 2695-5563 卢比),相当于几乎 2 个月的家庭收入。

结论

2008 年,在比哈尔邦的初级卫生保健服务中,VL 病例管理仍存在严重缺陷:陈旧的锑剂使用,失败率高,患者延迟时间长。为了实现 VL 消除目标,需要更积极的病例发现策略,并且可以更多地利用村庄卫生工作者网络。患者的费用仍然是早期发现病例的障碍。

相似文献

1
Management of visceral leishmaniasis in rural primary health care services in Bihar, India.
Trop Med Int Health. 2010 Jul;15 Suppl 2(Suppl 2):55-62. doi: 10.1111/j.1365-3156.2010.02562.x.
2
Village health workers in Bihar, India: an untapped resource in the struggle against kala-azar.
Trop Med Int Health. 2013 Feb;18(2):188-93. doi: 10.1111/tmi.12031. Epub 2012 Dec 20.
3
Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India.
Trop Med Int Health. 2006 Nov;11(11):1715-24. doi: 10.1111/j.1365-3156.2006.01732.x.
5
Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia.
PLoS One. 2014 Jun 18;9(6):e100220. doi: 10.1371/journal.pone.0100220. eCollection 2014.
6
Efficacy of oral miltefosine in visceral leishmaniasis in rural West Bengal, India.
Indian J Pharmacol. 2012 Jul-Aug;44(4):500-3. doi: 10.4103/0253-7613.99326.
7
Pharmacovigilance of Miltefosine in Treatment of Visceral Leishmaniasis in Endemic Areas of Bihar, India.
Am J Trop Med Hyg. 2016 Nov 2;95(5):1100-1105. doi: 10.4269/ajtmh.16-0242. Epub 2016 Sep 19.
8
Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy.
PLoS Negl Trop Dis. 2009;3(1):e355. doi: 10.1371/journal.pntd.0000355. Epub 2009 Jan 13.
10

引用本文的文献

2
Mathematical modelling of the use of insecticide-treated nets for elimination of visceral leishmaniasis in Bihar, India.
R Soc Open Sci. 2021 Jun 30;8(6):201960. doi: 10.1098/rsos.201960. eCollection 2021 Jun.
3
Development and Evaluation of Active Case Detection Methods to Support Visceral Leishmaniasis Elimination in India.
Front Cell Infect Microbiol. 2021 Mar 24;11:648903. doi: 10.3389/fcimb.2021.648903. eCollection 2021.
5
Post kala azar dermal leishmaniasis and leprosy prevalence and distribution in the Muzaffarpur health and demographic surveillance site.
PLoS Negl Trop Dis. 2019 Oct 25;13(10):e0007798. doi: 10.1371/journal.pntd.0007798. eCollection 2019 Oct.
6
Eliminating visceral leishmaniasis in South Asia: the road ahead.
BMJ. 2019 Jan 22;364:k5224. doi: 10.1136/bmj.k5224.
7
Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India.
PLoS Negl Trop Dis. 2018 Dec 6;12(12):e0006888. doi: 10.1371/journal.pntd.0006888. eCollection 2018 Dec.
8
Visceral leishmaniasis cyclical trends in Bihar, India - implications for the elimination programme.
Gates Open Res. 2018 Feb 21;2:10. doi: 10.12688/gatesopenres.12793.1.
10
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge.
PLoS Negl Trop Dis. 2017 Dec 14;11(12):e0006052. doi: 10.1371/journal.pntd.0006052. eCollection 2017 Dec.

本文引用的文献

1
Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India.
Am J Trop Med Hyg. 2010 Jan;82(1):9-11. doi: 10.4269/ajtmh.2010.09-0235.
2
The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India.
Trop Med Int Health. 2009 Jun;14(6):639-44. doi: 10.1111/j.1365-3156.2009.02279.x. Epub 2009 Apr 20.
3
Can visceral leishmaniasis be eliminated from Asia?
J Vector Borne Dis. 2008 Jun;45(2):105-11.
4
Inequity in health care delivery in India: the problem of rural medical practitioners.
Health Care Anal. 2007 Sep;15(3):223-33. doi: 10.1007/s10728-007-0060-x.
5
Innovative lead discovery strategies for tropical diseases.
Nat Rev Drug Discov. 2006 Nov;5(11):941-55. doi: 10.1038/nrd2144.
6
Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India.
Trop Med Int Health. 2006 Nov;11(11):1715-24. doi: 10.1111/j.1365-3156.2006.01732.x.
7
Serological tests for visceral leishmaniasis.
BMJ. 2006 Oct 7;333(7571):711-2. doi: 10.1136/bmj.38989.567083.BE.
8
Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India.
Trop Med Int Health. 2006 Jun;11(6):899-905. doi: 10.1111/j.1365-3156.2006.01647.x.
10
Risk factors for kala-azar in Bangladesh.
Emerg Infect Dis. 2005 May;11(5):655-62. doi: 10.3201/eid1105.040718.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验